scorecardresearch
Monday, August 18, 2025
TopicCovid-19 treatment

Topic: Covid-19 treatment

80-year-old Covid patient who moved Delhi HC for free treatment dies before hearing date

The Delhi High Court was due to hear the octogenarian's petition seeking admission to a government hospital with ventilator facilities and free treatment.

SC asks private hospitals if they are ready to charge Covid patients at Ayushman Bharat rate

SC was hearing a PIL filed by advocate Sachin Jain who said private hospitals, which have been given land free of cost, should not charge for Covid-19 treatment.

Sun Pharma gets approval to test plant-based dengue drug for Covid treatment

Sun Pharma said human safety study of AQCH already completed, clinical trials will be conducted across 12 centres on 210 patients. The treatment duration will be 10 days.

SC seeks Modi govt’s response on plea to fix Covid treatment costs in private hospitals

A Kolkata resident has submitted that according to insurers, private hospitals are charging for Covid treatment ‘as per their whims and fancies’.

Lancet withdraws controversial study linking HCQ to higher Covid death risk over data issues

Three of the four authors of the study apologised to The Lancet's editors and readership for any embarrassment or inconvenience their published findings may have caused.

US’ Gilead Sciences enters India to boost supply of potential Covid drug remdesivir

Gilead Sciences says it will ‘work closely with the health authorities in India to provide guidance on anticipated drug supply based on local incidence and severity of disease’.

Lancet alert: ‘Serious scientific questions’ raised on HCQ study that led to WHO trial pause

Questions have been raised on the Lancet HCQ study over dataset and methodology. Another journal has issued similar concern over a study that used same data.

Modi govt to study WHO decision to halt HCQ trial, expert panel to review dosage

The suspension of WHO’s hydroxychloroquine clinical trial was to be taken up by an expert committee last week, but the discussions were eventually ‘deferred’.

India prepares to test Itolizumab, the drug credited for lowering Covid mortality in Cuba

The drug will go under trial in six hospitals in India, including AIIMS-Delhi, KEM Hospital in Mumbai and Narayana Health in Bengaluru. 

Sun Pharma gets approval to test pancreatitis drug nafamostat for Covid treatment

Sun Pharma says nafamostat has shown promise in fighting against the virus in in-vitro studies conducted by 3 groups of scientists in Europe, Japan and South Korea.

On Camera

History teaching requires revision more than textbooks

The kinds of revisions we’re seeing remove the very skills that make historical thinking meaningful. The result is a citizen who either dismisses history entirely or defends it without support.

Navigating Trump’s tariffs is no child’s play. Indian toymakers are losing out on orders, enquiries

Indian toymakers are now exploring new markets, but they want govt to negotiate a trade deal with US soon, introduce incentives and subsidies to make the industry more competitive.

What is Project Sudarshan Chakra, announced by Modi from ramparts of Red Fort

The project is meant to be a ‘protective shield that will keep expanding’, the PM said. It is on the lines of the ‘Golden Dome’ announced by Trump, it is learnt.

War of IAF, PAF doctrines: As Pakistan obsesses over numbers, India embraces risk, wins

Now that both IAF and PAF have made formal claims of having shot down the other’s aircraft in the 87-hour war in May, we can ask a larger question: do such numbers really matter?